“I really hope Arvinas becomes successful in bringing drugs to patients in need to help treat diseases that traditional small molecule drugs have not been able to treat yet. Hopefully, we will become the first PROTAC® company to have a drug available for patients.”

“What drives Arvinas is the patients. I am hopeful that this technology can target diseases where for years there has been little hope for a cure. There are so many patients who don’t have a great deal of therapeutic options and it would be amazing not only for those individuals but also their families.”

“I hope our organization’s growth continues and we continue to pursue it with excitement and passion. One of the deciding factors for me to join Arvinas was seeing how excited everybody was around the technology and around the prospects for the organization. So, my hope for the organization is that we continue to have this very vibrant community that is passionate about our growth.”